Aqilion AB Sustainability Reports
AQILION AB (publ) is a biotech company focused on drug discovery and early clinical development. It develops innovative treatments for diseases caused by chronic inflammation and dysfunctional immunological reactions.
Sector: Professional & technical services
Country: Sweden
Exchange: Unlisted
LEI: 549300P1QZ45IUTMJR27
No reports are currently available in our catalogue.